Curanex Pharmaceuticals Inc (CURX)
About Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$4.2M
- Total assets
- $11.6M
- Market cap
- $8.6M
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $4.2M
- Operating income
- -$4.2M
- Net income
- -$4.2M
- EPS (basic)
- $-0.17
- EPS (diluted)
- $-0.17
Balance sheet
- Total assets
- $11.6M
- Current assets
- $11.2M
- Total liabilities
- $361.0K
- Current liabilities
- $137.0K
- Shareholders’ equity
- $11.2M
Cash flow
- Operating cash flow
- -$10.5M
- Investing cash flow
- -$4.8M
- Financing cash flow
- $15.3M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $8.6M
- EPS (diluted)
- $-0.17
- Shares outstanding
- 45.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 26, 2025
Curanex Pharmaceuticals Inc (CURX) Stock Price
- Reported a net loss of $4.2M.
- Trading 98% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Curanex Pharmaceuticals Inc.
Write a review
News about Curanex Pharmaceuticals Inc
News & sentiment via Polygon.io
Curanex Pharmaceuticals Inc: frequently asked questions
Is Curanex Pharmaceuticals Inc an American company?
Curanex Pharmaceuticals Inc is a US-based company headquartered in Jericho, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Curanex Pharmaceuticals Inc headquartered?
Curanex Pharmaceuticals Inc is headquartered in Jericho, New York, United States.
Is Curanex Pharmaceuticals Inc publicly traded?
Yes — Curanex Pharmaceuticals Inc is a publicly traded company. Its stock trades under the ticker symbol CURX on the NASDAQ.
What does Curanex Pharmaceuticals Inc do?
Curanex Pharmaceuticals Inc is an American Pharmaceuticals company in the Health & Beauty sector.
